|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Eloxx Pharmaceuticals
| | | Phone: | (781) 577-5300 | Year Established: | 1999 | Ticker: | ELOX | Exchange: | NASDAQ | Main Contact: | Robert Ward, Chairman & CEO | | Other Contacts: | Greg Williams, PhD, COO David P. Snow, CBO Gregory Weaver, MBA, CFO
| | Company Description | Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates (designed to be eukaryotic ribosomal selective glycosides) that are designed to treat rare and ultra-rare premature stop codon diseases. | |
|
|
|
|
|